Bacterial intracellular processes

Bacterial intracellular processes refer to the complex network of biochemical reactions and molecular mechanisms that occur within a bacterial cell to maintain life, support growth, and enable reproduction (NIH, 2023). These processes include the replication of the bacterial genome, the transcription of RNA, the translation of proteins by ribosomes, and the synthesis of essential metabolites like folic acid (PubMed, 2021). In antimicrobial therapy, these intracellular pathways are the primary focus, as drugs are designed to inhibit specific bacterial enzymes or structural components that have no direct counterpart in human cells (StatPearls, 2023). For example, aminoglycosides and macrolides interfere with protein synthesis by binding to bacterial ribosomes, while quinolones inhibit DNA topoisomerases to prevent replication (Nature Reviews Microbiology, 2020). Because the term "Bacterial intracellular processes" describes a broad category of biological activities rather than a single protein or receptor, it is not classified as a discrete therapeutic target in drug discovery databases. Instead, it represents the physiological landscape where various specific targets, such as DNA gyrase or the 30S ribosomal subunit, reside and function (WHO, 2022). Effective targeting of these processes is the cornerstone of treating bacterial infections, though it requires overcoming challenges such as cell membrane permeability and the development of bacterial resistance mechanisms (ScienceDirect, 2022).

Other names

Bacterial metabolic pathwaysIntracellular bacterial targetsBacterial physiology

Inhibition of essential bacterial enzymes and structural components involved in nucleic acid synthesis, protein translation, and metabolic pathways.